Tioma Therapeutics, Inc. — Form D
Tioma Therapeutics, Inc. of BRISBANE, CA, a company, filed a Form D exempt-offering notice with the SEC on 2015-08-07. The offering totals $45.0M, of which $8.1M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2015-08-07
- Form: D
- Accession: 0001630680-15-000002
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $45.0M
- Amount sold: $8.1M
- Remaining: $36.9M
- Minimum investment: $50K
- Investors: 10
- Date of first sale: 2015-06-25
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-245292
Issuer
- Name: Tioma Therapeutics, Inc.
- CIK: 0001630680
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 2000 SIERRA POINT PARKWAY, SUITE 700, BRISBANE, CA, 94005
- Phone: 4156714024
Officers, directors & promoters (22)
| Name | Role | Location |
|---|
| Jill L Carroll | Director | Cambridge, MA |
| Robert W Karr | Director | SAINT LOUIS, MO |
| John W McKearn | Director | SAINT LOUIS, MO |
| Peter W Moldt | Director | SAINT LOUIS, MO |
| Kathleen L Beckmann | Executive Officer | SAINT LOUIS, MO |
| George L Capps | Executive Officer | SAINT LOUIS, MO |
| Pamela W Manning | Executive Officer | SAINT LOUIS, MO |
| Jill Carroll | Director | Palo Alto, CA |
| Charles Bolten | Director | St. Louis, MO |
| Carole L Nuechterlein | Director | Harrisburg, PA |
| BOBBY W SANDAGE, JR. | Director | ST. LOUIS, MO |
| Dan Broderick | Director | St. Louis, MO |
| Peter T Moldt | Director | San Francisco, CA |
| John T McKearn | Director | BRISBANE, CA |
| John T Donovan | Director | BRISBANE, CA |
| John T Donovan | Executive Officer | BRISBANE, CA |
| James L Stutz | Executive Officer | BRISBANE, CA |
| Pamela T Manning | Executive Officer | SAINT LOUIS, MO |
| Robert W Karr | Executive Officer | SAINT LOUIS, MO |
| Kalthleen L Beckmann | Executive Officer | SAINT LOUIS, MO |
| William Frazier | Director | SAINT LOUIS, MO |
| John L McKearn | Director | SAINT LOUIS, MO |
Other filings by this issuer (2)
More